Latest Research And Development News

Stakk Limited reports a staggering 2,533% quarter-on-quarter increase in annual recurring revenue to $472k, fueled by its acquisition of US-based Radical DBX and rapid expansion in Embedded Finance across Australia and the US.

Nanollose Limited has achieved a significant milestone by blending its Nullarbor-20™ sustainable fibre with Australian merino wool to produce pilot blankets, while also completing a $672,000 placement to fund ongoing commercialisation efforts.

Corella Resources has successfully completed a fully underwritten rights issue raising $935,487, positioning the company to advance exploration at its Tampu Project and consider new opportunities.

Nexus Minerals reports breakthrough regional exploration success at its Wallbrook Gold Project with two new significant gold discoveries and expanded mineralisation footprints, while progressing mine studies and permit applications.

Imagion Biosystems has progressed its MagSense HER2 breast cancer imaging agent towards a pivotal Investigational New Drug application with the FDA, backed by a solid funding runway exceeding 13 quarters.

InteliCare Holdings reported a net operating cash outflow of AUD 447,000 for Q1 2025 but remains confident in sustaining operations through active cash management and potential capital raises.

Heavy Rare Earths Limited (ASX:HRE) has expanded its uranium exploration footprint through a significant asset acquisition in South Australia and advanced geophysical surveys, positioning itself for targeted drilling in 2025.

Cobalt Blue Holdings progresses its Kwinana Cobalt Refinery towards a Final Investment Decision while expanding into copper and base metals through the Halls Creek Project. The cobalt market faces a structural shift amid DRC export restrictions, supporting a strategic corporate rebrand and leadership changes.

Volt Group Limited reported a robust 26.8% revenue increase in Q1 FY25, driven by strong performances in its EcoQuip and Wescone divisions, alongside promising advances in its ATEN Waste Heat to Power technology.

Empire Energy Group is advancing its Carpentaria-5H well hydraulic stimulation scheduled for June 2025, alongside preparations for the Carpentaria Gas Plant construction, aiming to commence gas sales from EP187 by late 2025 or early 2026.

Avecho Biotechnology has inked a decade-long exclusive licensing agreement with Sandoz for its pharmaceutical-grade cannabidiol capsule targeting insomnia in Australia, backed by a US$3 million upfront payment and promising milestone and royalty streams.

Blue Energy has resolved a significant legal hurdle by securing an amended Environmental Authority for its Sapphire asset, enabling progression of the Petroleum Lease 1034 and continued pilot production testing despite operational interruptions.